-
Sep 13, 2021, 01:00
by
Jaida Montenegro
On September 9th, the Michigan Society of Addiction Medicine (MISAM) submitted a comment letter to the Michigan Bureau of Professional Licensing in support of proposed changes to the pharmacy controlled substances rules of the Drug Treatment Prescriber Program. These revisions would eliminate burdensome requirements on the licensing of controlled substances and bring the state rules into closer alignment with federal standards.
Full story
-
Sep 2, 2021, 01:00
by
Jaida Montenegro
On September 1st, the Michigan Society of Addiction Medicine (MISAM) sent a letter to Director Hawks of the Michigan Department of Licensing and Regulatory Affairs (LARA) to highlight concerns about the department’s regulation of medication for addiction treatment (MAT).
Full story
-
Aug 31, 2021, 01:00
by
Jaida Montenegro
On August 23rd, ASAM joined with a coalition of 45 partner organizations to send a letter to the leadership of the House Energy and Commerce Committee in support of the Moms Matter Act (H.R. 909).
Full story
-
Aug 24, 2021, 01:00
by
Jaida Montenegro
On August 24th, ASAM sent a letter to Representative Cohen affirming its strong support for the Making Essentials Affordable and Lawful (MEAL) Act of 2021 (H.R. 2837). This proposed legislation would remove the federal ban prohibiting individuals with felony drug convictions from receiving Supplemental Nutrition Assistance Program (SNAP) and Temporary Assistance for Needy Families (TANF) benefits.
Full story
-
Aug 18, 2021, 16:20
by
admin admin
Full story
-
Aug 18, 2021, 16:19
by
admin admin
Full story
-
Aug 18, 2021, 01:00
by
Jaida Montenegro
On August 9th, the Kentucky Society of Addiction Medicine (KYSAM) sent a letter to President Shuffett of the Kentucky Board of Medical Licensure (KBML), responding to KBML’s recently published Board Opinion Relating to Online/Virtual Medication Assisted Treatment.
Full story
-
Aug 14, 2021, 01:00
by
admin admin
ASAM and 124 other organizations urged congressional leadership to pass legislation that would permit Medicaid to support essential health care for 30 days prior to release and upon reentry.
Full story
-
Aug 9, 2021, 13:41
by
admin admin
Full story
-
Aug 9, 2021, 13:40
by
admin admin
This Week in the Weekly..
We have some important articles this week about opioids. An interesting study from the journal Nature found that people with COVID-19 exhibit higher risk of death and health resource utilization beyond the first 30 days of illness and more specifically, have an increased use of pain medications, antidepressants and anxiolytics along with other prescribed medications.
- Editor-in-Chief: Nicholas Athanasiou, MD , MBA , FASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
This Week in the Weekly…
The federal government has been making some headlines: the Biden administration is extending a ban on fentanyl-like substances (NBC News), proposing a ban on menthol cigarettes (NY Times), and most importantly (especially if you were a little heartbroken back in January), HHS is relaxing the recommendations to prescribing buprenorphine (HHS.gov).
- Editor-in-Chief: Nicholas Athanasiou, MD , MBA , FASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
This week I have the remarkable opportunity to sit on a (virtual) dais sponsored by the American Bar Association, on endemic opioid use disorder. I get to bask in the rays of knowledge of many fine minds and assiduous pathfinders. Among these will be our own advocacy staff, who have been central to the writing of our opioid used disorder (OUD) treatment policy for correctional facilities, as well as policies for those among our membership seeking or needing assistance. Participating will be Presidents of the ABA, the AMA, the APA, and ASAM. It’s a pretty remarkable forum. And it stimulates attention to several websites, including ASAM’s own ASAM Treatment in Correction Settings Toolkit and the ASAM Public Policy Statement on Treatment of Opioid Use Disorder in Correctional Settings
- Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
For some decades, Dr. Tom Kosten and associates have pursued the tantalizing possibility of a cocaine immunization, a vaccination that would result in the excretion or at least inactivation of the drug. This was taken less-seriously than was warranted by many at the time, largely from a failure among those many to understand the underlying principle – binding of a small molecule, cocaine, with a more recognizable and larger molecule, to template a vaccine. In the interval since his initial work, there have been many efforts to create similar immunizations, discussions of which I have sampled here. Most of these are journalistic essays but provide a quick snapshot of the intentions, and the relative successes, for a variety of drug classes.
This was brought to mind by two associations: Dr. Athanasiou’s reminder that April 20, or “420” is a banner for the cannabis-using community, mythologically related to 4:20 PM and the usual end of the high school day. (There is also “710”, “OIL” upside-down and thus celebrated on July the 10th, suggesting two distinct quasi-religious sects; but I digress.) The other was the persistent, pervasive presence of the COVID-19 pandemic and the efforts to produce effective immunizations; a loose, but not completely tangential association. Among those immunizing efforts against drug actions, there has been exploration of approaches that would block the more toxic synthetic cannabinoids subsumed under the umbrella of “spice.”
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
For ASAM Weekly readers who are not themselves ASAM members, you are owed an update on the parent organization’s activities at this time of year.
Over the course of one week, all committees, councils, officers, and members of the Board of Directors will transition, replacing and being replaced by elected and appointed members. The weekend following, ASAM holds its annual scientific conference. For most of us who are involved in instruction or regional continuing medical education, conferences tend to be stacked up at this time of year; in a shameless plug, the Hawaii Addictions Conference provides an example of how inexpensive and how increasingly well-wrought the online trainings can be [ https://blog.hawaii.edu/dop/hac-2021/ ]. All of this by way of reintroducing a solicitation for Assistant Editors, as education at all levels is a fundamental obligation of the Society.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
The article below cited in the journal Addiction examines the effectiveness of e-cigarettes for smoking cessation. Apart from underlining differences between American and British views of the marketing of medications and appliances, it underscores an important philosophic difference in the definition of the illness state. In the most recent American iteration of diagnostic language (DSM5), the addiction that involves nicotine is referred to as a tobacco use disorder. This has resulted in a particular focus on smokable (combustible) tobacco products as the agent of harm or as the basis for a description of the illness.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
The Washington Monthly item at the end of this week’s issue deserves some contemplation. The notion that our stress on addiction as a “… brain disease” may actually be counterproductive, is itself counterintuitive. And yet it is less so if you consider addiction to be the outcome of multiple forces and conditions. It is surely the case that increasingly effective medication aids in recovery; and equally, that recovery is more than a replenishment of some neurotransmitters, and inhibition of others. Yuval Noah Harari (Homo Deus, ch.3) would have us understand that cooperation is requisite to effect change in human behavior. So also would most who belong to community recovery programs, lead psychotherapy seminars, and the like.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
The readers may be best served this week with a renewed link to the 25 February 2021 policy on racial justice.
My understanding of social movements is that they are most likely to be successful if 1) their adoption costs the opposition nothing tangible; 2) they are tied to a shared, positive experience (as in “marriage”); and 3) they are persistent, as the drumming of raindrops on a stone. Brevity helps; the linked document is all of 4 pages before the references, and its recommendations occupy only one page. Perhaps start with the “Recommendations”, please, and then you will feel your time best-respected.
If you find the concepts and the reasoning are exportable to your own work or other professional setting, please cite freely. The greater the concord, the greater the momentum to long-delayed remedies.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
The world seems always to seek a newer agent that will bring us to a new level of pleasure, of joy. I have paraphrased Don Draper of Madmen before in his asking, "What is happiness? Happiness is the moment before you need more happiness.” The review article on cannabis (Journal of Psychopharmacology ) below brings the Senior Editor to mind of a previous initiative involving an alcohol substitute that was ostensibly hangover-free, "Alcosynth." The players may differ but the game’s objective stays the same: pleasure without consequences. Whether it is a "nonaddictive” opioid substitute, such as pentazocine (Talwin), meperidine (Demerol), or tramadol (Ultram); vaporized nicotine in place of tobacco fumigation (to supposedly evade damages resulting from tobacco smoke); benzos vs. barbs; or even synthetic sweeteners in that 32 oz. Big Gulp, the alchemists’ search for the hedonic Philosopher’s Stone never abates.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
Our medical school hosts a weekend curriculum for lay community members, many of whom are retired or have relatives working in medicine. It is spread across several months, and I was asked to speak last week about substance use in the elderly. After the event, I was thrown more than a dozen questions. My responses did not satisfy me in several instances, but you do what you can do when you're standing at a podium in front of 100 potential donors to the school. The show must go on. I don’t expect all in the readership to agree with my answers – after all, a good many of you are certainly smarter than I, or at least more cautious. Here are a few of the audience’s Q & A items:
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story
-
Aug 9, 2021, 13:40
by
admin admin
Last week carried the hope of a real holiday, Presidents’ Day; or at least one for the Feds, with the possibility of a trickle-down effect. But by Wednesday, any elation experienced at the prospect of a four-day workweek had been blown either into the Gulf of Mexico or across the Great Lakes by a fierce and unrelenting winter assault. My words of sympathy to colleagues in virtual conferences or just on telephone calls most likely sounded taunting, even micro-aggressive. How could it not? With our own winter weather in Hawai`i dropping at night down to 69°, we’ve not a lot of justification for lamentation.
- Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
Full story